Mammalian target of rapamycin and tuberous sclerosis complex-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mammalian target of rapamycin and tuberous sclerosis complex

Published:2015-08 Issue:2 Volume:79 Page:93-100
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Wataya-Kaneda Mari

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Ministry of Health, Labor and Welfare of Japan

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference50 articles.

1. TOR signaling in growth and metabolism;Wullschleger;Cell,2006

2. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery;Kim;Cell,2002

3. The proline-rich Akt substrate of 40kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1;Oshiro;J Biol Chem,2007

4. Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly;Kaizuka;J Biol Chem,2010

5. Rheb promotes cell growth as a component of the insulin/TOR signalling network;Saucedo;Nat Cell Biol,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na+/K+-ATPase;Molecular Biology Reports;2024-04-15

2. Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus;Frontiers in Pediatrics;2024-02-21

3. Redox Regulation in Hematology and Stem Cell Research;Comprehensive Hematology and Stem Cell Research;2024

4. Advances in the regulatory mechanisms of mTOR in necroptosis;Frontiers in Immunology;2023-12-18

5. Metformin attenuates inflammation and boosts autophagy in the liver and intestine of chronologically aged rats;Experimental Gerontology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3